21004 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Somatostatins
Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes
#302Sustained Release Formulation Comprising Octreotide and Two or More Polylactide-Co-Glycolide Polymers
#303Conjugate of Biomacromolecule with Bioreductive and Preparative Method Thereof
#304Method and Composition for the Treatment of Cardiac Hypertrophy
#305Pharmaceutical lipid compositions
#306Neuroendocrine tumor treatment
#307Induction of differential stress resistance and uses thereof
#308Somatostatin antagonists
#309Aryloxy-substituted benzimidazole derivatives
#310COMPOSITIONS AND METHODS FOR TREATING DISEASES THROUGH INHIBITION OF DNA METHYLATION AND HISTONE DEACETYLASE
#311Liquid depot formulations
#312Biocompatible stent
#313SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR TREATING INSULIN INSENSITIVITY AND SYNDROME X
#314Somatostatin antagonists
#315Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parenteral administration and preparation process
#316Biomarkers for the Efficacy of Somatostatin Analogue Treatment
#317Opioid depot formulations
#318Process of preparing microspheres for sustained release having improved dispersibility and syringeability
#319Method of modulating the proliferation of medullary thyroid carcinoma cells
#320Electrical stimulation of iliohypogastric nerve to alleviate chronic pelvic pain
#321Drug delivery to ilioinguinal nerve to alleviate chronic pelvic pain
#322Drug delivery to iliohypogastric nerve to alleviate chronic pelvic pain
#323Intraspinal Drug Delivery Methods and Devices To Alleviate Chronic Pelvic Pain
#324Microparticles comprising somatostatin analogues
#325Short interfering RNA (siRNA) analogues
#326Use of somatostatin or one of its analogues for preparing a medicament intended to regulate the ovarian follicular reserve in non-menopausal women
#327Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
#328Treatment process using somatostatin analogues
#329Stable solid forms of enterostatin
#330Therapy procedure for drug delivery for trigeminal pain
#331Pharmaceutical composition comprising cyclic somatostatin analogues
#332Controlled release compositions
#333Compositions of lipids and cationic peptides
#334Methods for treatment of headaches by administration of oxytocin
#335Anticancer therapy
#336Encapsulation of water soluble peptides
#337Prophylaxis and/or treatment of portal hypertension
#338Stable topical drug delivery compositions
#339Use of neuropeptides for traumatic cartilage injury
#340Remedy for corneal failure
#341Sustained release of microcrystalline peptide suspensions
#342Sustained release of microcrystalline peptide suspensions
#343Method for decreasing body weight using a somatostatin receptor agonist
#344Controlled release formulations of octreotide
#345Solvent/polymer solutions as suspension vehicles
#346Modulation of the neuroendoctrine system as a therapy for motor neuron disease
#347Buccal, polar and non-polar spray containing sumatriptan
#348Methods of delivering stable topical drug compositions
#349Phosphorylated polymers and conjugates thereof
#350Sustained release ionic conjugate
#351Topical drug delivery using phosphatidylcholine
#352Selective treatment of endothelial somatostatin receptors
#353Glp-1 and methods for treating diabetes
#354Use of somatostatin analogs in sleep apnea
#355Pharmaceutical compositions for controlled release delivery of biologically active compounds
#356Lactone bearing absorbable polymers
#357Method of inhibiting fibrosis with a somatostatin agonist
#358Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase
#359Therapeutical conversion
#360Method of modulating the proliferation of medullary thyroid carcinoma cells
#361Sustained release ionic conjugate
#362Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides